Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente LANCET

Tipo Año Título Fuente
Artículo2024Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional studyLANCET
Otros2024Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation.LANCET
Artículo2023Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trialLANCET
Artículo2023Mpox in people with advanced HIV infection: a global case seriesLANCET
Artículo2023Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trialLANCET
Artículo2022Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialLANCET
Artículo2022Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysisLANCET
Artículo2022Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialLANCET
Artículo2022Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countriesLANCET
Artículo2022Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trialLANCET
Artículo2022Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trialLANCET
Artículo2022Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort studyLANCET
Artículo2021Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialLANCET
Artículo2021Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trialLANCET
Artículo2021Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)LANCET
Artículo2021Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialLANCET
Artículo2020Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trialLANCET
Artículo2020Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort studyLANCET
Letter2020Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workersLANCET
Artículo2019Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trialLANCET
Artículo2019Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational studyLANCET
Letter2017Mortality decrease according to socioeconomic groups - Author's replyLANCET
Artículo2016Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trialLANCET
Artículo2016Mortality decrease according to socioeconomic groups during the economic crisis in Spain: a cohort study of 36 million peopleLANCET
Editorial2015The evolving role of CETP inhibition: beyond HDL cholesterolLANCET
Letter2014Lessons from the SPS3 trialLANCET
Artículo2012Mortality after surgery in Europe: a 7 day cohort studyLANCET
Reseña2007Mental health systems in countries: where are we now?LANCET
Letter2007Severe acute hepatitis in a patient treated with anastrozoleLANCET
Letter2002Leishmania spp infection in injecting drug usersLANCET
Artículo2001Acute tubulointerstitial nephritis associated with the selective COX-2 enzyme inhibitor, rofecoxibLANCET
Letter2001HIV-1 progression in hepatitis-C-infected drug usersLANCET
Letter2001HIV-1 progression in hepatitis-C-infected drug users [3] (multiple letters)LANCET
Artículo2001Human papillomavirus genotypes in rural MozambiqueLANCET
Artículo1998Quinolone resistance from a transferable plasmidLANCET
Letter1996Pneumocystis carinii infection in patients with chronic bronchial diseaseLANCET
Letter1995Hepatitis E virus and HIV infection in homosexual menLANCET
Letter1995IMMUNOSUPPRESSION INDUCED BY HEPATITIS-C VIRUS-INFECTION REDUCES ACUTE RENAL-TRANSPLANT REJECTIONLANCET
Artículo1988Prevention of post-transfusion non-a, non-b hepatitis by non-specific immunoglobulin in heart-surgery patientsLANCET
Letter1983INCREASED FREQUENCY OF HLA-DR5 IN LYMPHADENOPATHY STAGE OF AIDSLANCET
Letter1980DIGOXIN LEVELS AND DIAZEPAMLANCET
Letter1974SEZARY SYNDROMELANCET